AKT1 and hepatocellular carcinoma: Thus, bufalin exhibits multiple anti-tumor effects on hepatoma cells because the mechanisms underlying bufalin action appears to mediate AKT/GSK3β/β-catenin/E-cadherin signaling and affect regulation of protein expression.